Search

everythinglearnresearchcommunity

for

Search:↓

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Merkel cells may have roles in sensing magnetic fields, creating fingerprints, Reiki energy healing, passing on environmental information to offspring, and influencing hair shape.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

A reliable method was developed to measure dutasteride in tablets accurately and consistently.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.